Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNathania, Karine-
dc.description.abstractGlobally, colorectal cancer remains the third most common cancer to be diagnosed. Nonetheless, there are current therapies for colorectal cancer, including radiotherapy, chemotherapy, and surgery. Unfortunately, overuse of chemotherapy can lead to chemoresistance to specific chemotherapeutic agents. For instance, late-stage colorectal cancer is treated with oxaliplatin. On the other hand, overuse of these drugs may result in colorectal cancer cells resistant to oxaliplatin. Fortunately, some substances could solve this issue, namely quercetin and levan. In this research, the methodology used is cell viability assay by MTT towards HCT116, a software to determine the synergistic effect for the drug combinations, cell cycle, and apoptosis analysis using flowcytometry to detect the staining molecule as well as western blot. It turns out quercetin and levan show a synergistic effect and improve cell death compared to the control as well as quercetin, it modulates the function of p53, cleavage of PARP, and a possible cleavage of caspase-3 keywords: exopolysaccharides, plant flavonoids chemoresistance,colorectal canceren_US
dc.publisherIndonesia International Institute for Life Sciencesen_US
dc.relation.ispartofseriesEP BM-013;EP24-055-
dc.subjectplant flavonids chemoresistanceen_US
dc.subjectcolorectal canceren_US
dc.titleInvestigation of Quercetin and Pantoea agglomerans Exopolysaccharides Direct Combinational to Induce Anti-cancer Activity Towards Chemoresistant Colorectal Cancer Cellsen_US
dc.typeWorking Paperen_US
Appears in Collections:Biomedicine

Files in This Item:
File Description SizeFormat 
  Restricted Access
Full Text1.08 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.